Synthesis and antiviral evaluation of 7-O-arylmethylquercetin derivatives against SARS-associated coronavirus (SCV) and hepatitis C virus (HCV)

Archives of Pharmacal Research

Volumn 35, Issue 1, 2012, Pages 77-85

  Park, Hye Ri ^a   Yoon, Hyunjun ^a   Kim, Mi Kyoung ^a   Lee, Sung Dae ^b   Chong, Youhoon ^a  

^a Konkuk University   (South Korea)

^b National Institute of Animal Science   (South Korea)

Author keywords

Arylmethyl; Hepatitis C; Quercetin; Severe acute respiratory syndrome (SARS)

Indexed keywords

2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 7 (2 IODOBENZYLOXY) 4H CHROMEN 4 ONE; 2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 7 (2 METHYLBENZYLOXY) 4H CHROMEN 4 ONE; 2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 7 (2 NITROBENZYLOXY) 4H CHROMEN 4 ONE; 2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 7 (3 IODOBENZYLOXY) 4H CHROMEN 4 ONE; 2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 7 (3 METHOXYBENZYLOXY) 4H CHROMEN 4 ONE; 2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 7 (3 METHYLBENZYLOXY) 4H CHROMEN 4 ONE; 2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 7 (3 NITROBENZYLOXY) 4H CHROMEN 4 ONE; 2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 7 (4 IODOBENZYLOXY) 4H CHROMEN 4 ONE; 2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 7 (4 METHOXYBENZYLOXY) 4H CHROMEN 4 ONE; 2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 7 (4 METHYLBENZYLOXY) 4H CHROMEN 4 ONE; 2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 7 (4 NITROBENZYLOXY) 4H CHROMEN 4 ONE; 2 (3,4 DIHYDROXYPHENYL) 7 (2 FLUOROBENZYLOXY) 3,5 DIHYDROXY 4H CHROMEN 4 ONE; 2 (3,4 DIHYDROXYPHENYL) 7 (3 FLUOROBENZYLOXY) 3,5 DIHYDROXY 4H CHROMEN 4 ONE; 2 (3,4 DIHYDROXYPHENYL) 7 (4 FLUOROBENZYLOXY) 3,5 DIHYDROXY 4H CHROMEN 4 ONE; 2 [[2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 4 OXO 4H CHROMEN 7 YLOXY]METHYL]BENZO NITRILE; 3 [[2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 4 OXO 4H CHROMEN 7 YLOXY]METHYL]BENZO NITRILE; 4 [[2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 4 OXO 4H CHROMEN 7 YLOXY]METHYL]BENZO NITRILE; 7 (2 BROMOBENZYLOXY) 2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 4H CHROMEN 4 ONE; 7 (2 CHLOROBENZYLOXY) 2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 4H CHROMEN 4 ONE; 7 (3 BROMOBENZYLOXY) 2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 4H CHROMEN 4 ONE; 7 (3 CHLOROBENZYLOXY) 2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 4H CHROMEN 4 ONE; 7 (4 BROMOBENZYLOXY) 2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 4H CHROMEN 4 ONE; 7 (4 CHLOROBENZYLOXY) 2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 4H CHROMEN 4 ONE; 7 (BENZYLOXY) 2 (3,4 DIHYDROXYPHENYL) 3,5 DIHYDROXY 4H CHROMEN 4 ONE; 7 O ARYLMETHYLQUERCETIN DERIVATIVE; ANTIVIRUS AGENT; QUERCETIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG SCREENING; DRUG SYNTHESIS; HEPATITIS C VIRUS; SARS CORONAVIRUS;

ANTIVIRAL AGENTS; CELL LINE, TUMOR; HEPACIVIRUS; HUMANS; QUERCETIN; SARS VIRUS; VIRUS REPLICATION;

EID: 84863122136     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-012-0108-9     Document Type: Article

References (15)

1. M. Amoros C. M. O. Simös L. Girre F. Sauvager M. Cormier 1992 Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis J. Nat. Prod. 55 1732 1740 1338212 10.1021/np50090a003 1:CAS:528:DyaK3sXlsF2ksw%3D%3D (Pubitemid 23023259)
2. D. R. Ferry A. Smith J. Malkhandi D. W. Fyfe P. G. de Takats D. Anderson J. Baker D. J. Kerr 1996 Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition Clin. Cancer Res. 2 659 668 9816216 1:CAS:528:DyaK28Xis1Wltbg%3D (Pubitemid 26133468)
3. A. Gozdek I. Zhukov A. Polkowska J. Poznanski A. Stankiewicz-Drogon J. M. Pawlowicz W. Zagorski-Ostoja P. Borowski A. Boguszewska-Chachulska 2008 NS3 Peptide, a novel potent hepatitis C virus NS3 helicase inhibitor: Its mechanism of action and antiviral activity in the replicon system Antimicrob. Agents Chemother. 52 393 401 18039921 10.1128/AAC.00961-07 1:CAS:528: DC%2BD1cXhtlSqtb4%3D (Pubitemid 351170805)
4. S. Harada E. Haneda T. Maekawa Y. Morikawa S. Funayama N. Nagata K. Ohtsuki 1999 Casein kinase II (CK-II)-mediated stimulation of HIV-1 reverse transcriptase activity and characterization of selective inhibitors in vitro Biol. Pharm. Bull. 22 1122 1126 10549869 10.1248/bpb.22.1122 1:CAS:528:DyaK1MXmslCqtbc%3D (Pubitemid 29507957)
5. T. N. Kaul E. Middleton Jr. P. L. Ogra 1985 Antiviral effect of flavonoids on human viruses J. Med. Virol. 15 71 79 2981979 10.1002/jmv. 1890150110 1:CAS:528:DyaL2MXpt1yjsg%3D%3D (Pubitemid 15184364)
6. J. Kim K.-S. Kim H. S. Lee K.-S. Park S. Y. Park S.-Y. Kang S. J. Lee H. S. Park D.-E. Kim Y. Chong 2008 Effects of the aryl linker and the aromatic substituent on the anti-HCV activities of aryl diketoacid (ADK) analogues Bioorg. Med. Chem. Lett. 18 4661 4665 18644717 10.1016/j.bmcl.2008.07.008 1:CAS:528:DC%2BD1cXps1Skt70%3D
7. D. W. Lamson M. S. Brignall 2000 Antioxidant and cancer III: quercetin Altern. Med. Rev. 5 196 208 10869101 1:STN:280:DC%2BD3czivVSmuw%3D%3D
8. C. Lee J. M. Lee N.-R. Lee D.-E. Kim Y.-J. Jeong Y. Chong 2009 Investigation of the pharmacophore space of severe acute respiratory syndrome coronavirus (SARSCoV) NTPase/helicase by dihydroxychromone derivatives Bioorg. Med. Chem. Lett. 19 4538 4541 19625187 10.1016/j.bmcl.2009.07.009 1:CAS:528:DC%2BD1MXptVCktb8%3D
9. C. Lee J. M. Lee N.-R. Lee B.-S. Jin K. J. Jang D.-E. Kim Y.-J. Jeong Y. Chong 2009 Aryl diketoacids (ADK) selectively inhibit duplex DNA-unwinding activity of SARS coronavirus NTPase/helicase Bioorg. Med. Chem. Lett. 19 1636 1638 19233643 10.1016/j.bmcl.2009.02.010 1:CAS:528:DC%2BD1MXjtVSlsb0%3D
10. H. S. Lee K.-S. Park C. Lee B. Lee D.-E. Kim Y. Chong 2010 7-O-Arylmethylgalangin as a novel scaffold for anti-HCV agents Bioorg. Med. Chem. Lett. 20 5709 5712 20797857 10.1016/j.bmcl.2010.08.012 1:CAS:528:DC%2BC3cXhtFGntrfN
11. M. Li X. Han B. Yu 2003 Facile synthesis of flavonoid 7-Oglycosides J. Org. Chem. 68 6842 6845 12919064 10.1021/jo034553e 1:CAS:528: DC%2BD3sXlvVGlt78%3D (Pubitemid 37011006)
12. V. Lohmann F. Korner J. Koch U. Herian L. Theilmann R. Bartenschlager 1999 Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line Science 285 110 113 10390360 10.1126/science.285.5424.110 1:CAS:528: DyaK1MXksVCqurk%3D (Pubitemid 29307577)
13. S. K. Sabui R. V. Venkateswaran 2003 Synthesis of O-methyl epi-heliannuol E Tetrahedron 59 8375 8381 10.1016/j.tet.2003.08.059 1:CAS:528: DC%2BD3sXns12qs74%3D (Pubitemid 37177022)
14. R. Vrijsen L. Everaert A. Boeyé 1988 Antiviral activity of flavones and potentiation by ascorbate J. Gen. Virol. 69 1749 1751 2839607 10.1099/0022-1317-69-7-1749 1:CAS:528:DyaL1cXks1Kgurw%3D
15. J. M. Vroljk A. Kaul B. E. Hansen V. Lohmann B. L. Haagmans S. W. Schalm R. Bartenschlager 2003 A repliconbased bioassay for the measurement of interferons in patients with chronic hepatitis C J. Virol. Methods 110 201 209 10.1016/S0166-0934(03)00134-4 (Pubitemid 36645265)